DDX41 and systemic lupus erythematosus: We found that there was no significant difference between IgG against H31–19 and any of the modified peptides in the SLE patients (P≥0.084, Figure 1, A and B), suggesting that the IgG Abs were mainly against the shared epitopes on the peptides.